Filippi Massimo, Bar-Or Amit, Piehl Fredrik, Preziosa Paolo, Solari Alessandra, Vukusic Sandra, Rocca Maria A
Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Nat Rev Dis Primers. 2018 Nov 22;4(1):49. doi: 10.1038/s41572-018-0050-3.
In the originally published version of this article, in Table 4, Ocrelizumab was incorrectly referred to as an anti-CD25 antibody. This has been corrected in the HTML and PDF versions of the article to an anti-CD20 antibody.
在本文最初发表的版本中，表4里奥瑞珠单抗被错误地称为抗CD25抗体。在本文的HTML和PDF版本中已将其更正为抗CD20抗体。
